Personalis Inc (PSNL)
5.52
+0.52
(+10.40%)
USD |
NASDAQ |
Nov 05, 14:48
Personalis Shareholders Equity (Quarterly): 112.27M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 112.27M |
| March 31, 2024 | 120.69M |
| December 31, 2023 | 129.44M |
| September 30, 2023 | 151.21M |
| June 30, 2023 | 176.09M |
| March 31, 2023 | 193.63M |
| December 31, 2022 | 218.14M |
| September 30, 2022 | 242.40M |
| June 30, 2022 | 264.63M |
| March 31, 2022 | 286.72M |
| December 31, 2021 | 310.30M |
| September 30, 2021 | 325.30M |
| Date | Value |
|---|---|
| June 30, 2021 | 338.75M |
| March 31, 2021 | 348.42M |
| December 31, 2020 | 194.94M |
| September 30, 2020 | 203.54M |
| June 30, 2020 | 93.12M |
| March 31, 2020 | 99.20M |
| December 31, 2019 | 106.69M |
| September 30, 2019 | 111.39M |
| June 30, 2019 | 117.02M |
| March 31, 2019 | -20.29M |
| December 31, 2018 | -106.39M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
93.12M
Minimum
Jun 2020
348.42M
Maximum
Mar 2021
206.08M
Average
194.94M
Median
Dec 2020
Shareholders Equity (Quarterly) Benchmarks
| Repligen Corp | 1.986B |
| Myriad Genetics Inc | 740.50M |
| Axogen Inc | 95.69M |
| CareDx Inc | 264.67M |
| Perspective Therapeutics Inc | 341.00M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 185.50M |
| Total Liabilities (Quarterly) | 73.23M |
| Debt to Equity Ratio | 0.0203 |
| Current Ratio | 3.314 |
| Net Debt Paydown Yield | 0.12% |